Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

NVS established a 10b5-1 plan to sell its MNTA shares between 8/8/16 and 1/26/17:

https://www.sec.gov/Archives/edgar/data/1114448/000110465916138659/a16-16346_1sc13da.htm

During the past three days (including today), NVS sold ~260K shares, reducing its MNTA holding from 4.71M shares to 4.45M shares.

The 10b5-1 plan has a (undisclosed) lower bound on the MNTA share price, so there is no absolute requirement that NVS complete its divestiture by 1/26/17.